US Patent Issued to SYNTHEKINE on Sept. 15 for "Biased IL2 muteins methods and compositions" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,215, issued on Sept. 15, was assigned to SYNTHEKINE INC. (Menlo Park, Calif.).

"Biased IL2 muteins methods and compositions" was invented by Jan Emmerich (Redwood City, Calif.), Steve Kauder (San Carlos, Calif.), Scott Alan McCauley (San Francisco) and Martin Oft (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease."

The patent was filed on June 6, 2022, under App...